BeOne Medicines Ltd. ONC
12 insiders sold $351.8M on the market, none bought
Form 4Open-market buys and sales are the trades an insider chose to make. Grants, option exercises and shares withheld for tax are pay; they show under All.
A year of insider trades, day by day
Open-market buys and sales by officers and directors · Form 4, since Nov 24, 2025
$0 bought on 0 days, $351.8M sold on 30 days. Each square is a day; click one for its Form 4.
Buys and sales by insider
Who traded · Form 4, added up
| Insider | Bought | Sold | Latest |
|---|---|---|---|
| John Oyler Chief Executive Officer, Director |
- | $297.2M | Aug 12, 2026 |
| Xiaodong Wang Director |
- | $46.8M | Oct 27, 2026 |
| Chan Henry Lee SVP, General Counsel |
- | $3.4M | Nov 5, 2026 |
| Xiaobin Wu President and COO |
- | $1.4M | Aug 25, 2026 |
| Lai Wang President, Global Head of R&D |
- | $1.2M | Jun 23, 2026 |
| Titus B. Ball Principal Accounting Officer |
- | $760K | Nov 6, 2026 |
| Aaron Rosenberg Chief Financial Officer |
- | $524K | Aug 3, 2026 |
| Baker Bros. Advisors LP / 667, L.P. / Baker Bros. Advisors (GP) LLC / Baker Brothers Life Sciences LP / Felix Baker / Julian Baker Director |
- | $262K | May 22, 2026 |
| Margaret Dugan Director |
- | $66K | May 22, 2026 |
| Corazon (Corsee) D. Sanders Director |
- | $66K | May 22, 2026 |
| Alessandro Riva Director |
- | $66K | May 22, 2026 |
| Qingqing Yi Director |
- | $66K | Jun 1, 2026 |
Owned after: shares held right after the person's latest buy or sale, from the Form 4 the date links to. % of shares: that holding over the shares outstanding on the latest cover page. Only people who bought or sold in this period are listed, and options, restricted units and shares held by others are not counted, so the rows are not a total of what insiders own.
Trade by trade, newest first
Every trade · each date links to its Form 4
Of 170 open-market sales by officers and directors, 82 came in the 30 days before a 10-Q, a 10-K or a results 8-K. Dates only, from the filing index; most companies close the window for insider trades in the weeks before results, so a trade there is often under a 10b5-1 plan.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Nov 6, 2026 | Titus B. Ball | Sale | -1,533 | 622K |
| Nov 6, 2026 | Titus B. Ball | Sale | -26 | 11K |
| Nov 5, 2026 | Chan Henry Lee | Sale (10b5-1) | -660 | 264K |
| Nov 5, 2026 | Chan Henry Lee | Sale (10b5-1) | -455 | 183K |
| Oct 27, 2026 | Xiaodong Wang | Sale (10b5-1) | -880 | 313K |
| Oct 27, 2026 | Xiaodong Wang | Sale (10b5-1) | -1,440 | 512K |
| Oct 27, 2026 | Xiaodong Wang | Sale (10b5-1) | -1,239 | 443K |
| Oct 27, 2026 | Xiaodong Wang | Sale (10b5-1) | -1,681 | 603K |
| Oct 27, 2026 | Xiaodong Wang | Sale (10b5-1) | -1,280 | 460K |
| Oct 27, 2026 | Xiaodong Wang | Sale (10b5-1) | -320 | 115K |
| Oct 27, 2026 | Xiaodong Wang | Sale (10b5-1) | -2,331 | 845K |
| Oct 27, 2026 | Xiaodong Wang | Sale (10b5-1) | -8,148 | 3.0M |
| Oct 27, 2026 | Xiaodong Wang | Sale (10b5-1) | -2,841 | 1.0M |
| Oct 27, 2026 | Xiaodong Wang | Sale (10b5-1) | -3,965 | 1.4M |
| Oct 27, 2026 | Xiaodong Wang | Sale (10b5-1) | -6,903 | 2.5M |
| Oct 13, 2026 | Xiaodong Wang | Sale (10b5-1) | -7,167 | 2.5M |
| Oct 13, 2026 | Xiaodong Wang | Sale (10b5-1) | -10,361 | 3.6M |
| Oct 13, 2026 | Xiaodong Wang | Sale (10b5-1) | -5,681 | 2.0M |
| Oct 13, 2026 | Xiaodong Wang | Sale (10b5-1) | -6,558 | 2.3M |
| Oct 13, 2026 | Xiaodong Wang | Sale (10b5-1) | -1,260 | 445K |
| Sep 30, 2026 | Chan Henry Lee | Sale (10b5-1) | -1,115 | 418K |
| Sep 28, 2026 | Xiaodong Wang | Sale (10b5-1) | -160 | 57K |
| Sep 28, 2026 | Xiaodong Wang | Sale (10b5-1) | -120 | 43K |
| Sep 28, 2026 | Xiaodong Wang | Sale (10b5-1) | -40 | 14K |
| Sep 28, 2026 | Xiaodong Wang | Sale (10b5-1) | -2,241 | 809K |
| Sep 28, 2026 | Xiaodong Wang | Sale (10b5-1) | -4,239 | 1.5M |
| Sep 28, 2026 | Xiaodong Wang | Sale (10b5-1) | -3,499 | 1.3M |
| Sep 28, 2026 | Xiaodong Wang | Sale (10b5-1) | -3,419 | 1.2M |
| Sep 28, 2026 | Xiaodong Wang | Sale (10b5-1) | -2,047 | 749K |
| Sep 28, 2026 | Xiaodong Wang | Sale (10b5-1) | -14,525 | 5.3M |
| Sep 28, 2026 | Xiaodong Wang | Sale (10b5-1) | -738 | 271K |
| Sep 8, 2026 | Xiaodong Wang | Sale (10b5-1) | -1,181 | 408K |
| Sep 8, 2026 | Xiaodong Wang | Sale (10b5-1) | -2,841 | 983K |
| Sep 8, 2026 | Xiaodong Wang | Sale (10b5-1) | -1,517 | 527K |
| Sep 8, 2026 | Xiaodong Wang | Sale (10b5-1) | -1,721 | 599K |
| Sep 8, 2026 | Xiaodong Wang | Sale (10b5-1) | -7,492 | 2.6M |
| Sep 8, 2026 | Xiaodong Wang | Sale (10b5-1) | -10,688 | 3.7M |
| Sep 8, 2026 | Xiaodong Wang | Sale (10b5-1) | -6,569 | 2.3M |
| Sep 8, 2026 | Xiaodong Wang | Sale (10b5-1) | -6,278 | 2.2M |
| Sep 1, 2026 | Titus B. Ball | Sale | -132 | 47K |
| Aug 25, 2026 | Xiaobin Wu | Sale (10b5-1) | -280 | 106K |
| Aug 12, 2026 | John Oyler | Sale (10b5-1) | -1,980 | 702K |
| Aug 12, 2026 | John Oyler | Sale (10b5-1) | -2,515 | 896K |
| Aug 12, 2026 | John Oyler | Sale (10b5-1) | -15,396 | 5.5M |
| Aug 12, 2026 | John Oyler | Sale (10b5-1) | -20,899 | 7.5M |
| Aug 12, 2026 | John Oyler | Sale (10b5-1) | -14,102 | 5.1M |
| Aug 11, 2026 | John Oyler | Sale (10b5-1) | -13,695 | 4.9M |
| Aug 11, 2026 | John Oyler | Sale (10b5-1) | -8,081 | 2.9M |
| Aug 11, 2026 | John Oyler | Sale (10b5-1) | -14,569 | 5.3M |
| Aug 11, 2026 | John Oyler | Sale (10b5-1) | -11,568 | 4.2M |
| Aug 11, 2026 | John Oyler | Sale (10b5-1) | -13,403 | 4.9M |
| Aug 11, 2026 | John Oyler | Sale (10b5-1) | -5,211 | 1.9M |
| Aug 11, 2026 | John Oyler | Sale (10b5-1) | -3,176 | 1.2M |
| Aug 11, 2026 | John Oyler | Sale (10b5-1) | -1,200 | 440K |
| Aug 11, 2026 | John Oyler | Sale (10b5-1) | -4 | 1K |
| Aug 11, 2026 | Chan Henry Lee | Sale (10b5-1) | -2,666 | 960K |
| Aug 10, 2026 | John Oyler | Sale (10b5-1) | -67 | 23K |
| Aug 10, 2026 | John Oyler | Sale (10b5-1) | -2,813 | 990K |
| Aug 10, 2026 | John Oyler | Sale (10b5-1) | -3,673 | 1.3M |
| Aug 10, 2026 | John Oyler | Sale (10b5-1) | -6,717 | 2.4M |
| Aug 10, 2026 | John Oyler | Sale (10b5-1) | -3,476 | 1.2M |
| Aug 10, 2026 | John Oyler | Sale (10b5-1) | -12,418 | 4.4M |
| Aug 10, 2026 | John Oyler | Sale (10b5-1) | -15,869 | 5.7M |
| Aug 10, 2026 | John Oyler | Sale (10b5-1) | -45,044 | 16.2M |
| Aug 10, 2026 | John Oyler | Sale (10b5-1) | -21,254 | 7.6M |
| Aug 10, 2026 | John Oyler | Sale (10b5-1) | -3,680 | 1.3M |
| Aug 3, 2026 | Aaron Rosenberg | Sale | -1,157 | 362K |
| Jul 30, 2026 | Chan Henry Lee | Sale | -1,044 | 338K |
| Jul 22, 2026 | Chan Henry Lee | Sale (10b5-1) | -1,669 | 542K |
| Jul 21, 2026 | John Oyler | Sale (10b5-1) | -15,379 | 4.9M |
| Jul 21, 2026 | John Oyler | Sale (10b5-1) | -20,029 | 6.3M |
| Jul 21, 2026 | John Oyler | Sale (10b5-1) | -7,842 | 2.5M |
| Jul 21, 2026 | John Oyler | Sale (10b5-1) | -15,807 | 5.0M |
| Jul 21, 2026 | John Oyler | Sale (10b5-1) | -2,340 | 749K |
| Jul 20, 2026 | John Oyler | Sale (10b5-1) | -5,146 | 1.6M |
| Jul 20, 2026 | John Oyler | Sale (10b5-1) | -6,273 | 1.9M |
| Jul 20, 2026 | John Oyler | Sale (10b5-1) | -2,907 | 906K |
| Jul 20, 2026 | John Oyler | Sale (10b5-1) | -15,499 | 4.8M |
| Jul 20, 2026 | John Oyler | Sale (10b5-1) | -14,326 | 4.5M |
| Jul 20, 2026 | John Oyler | Sale (10b5-1) | -1,850 | 581K |
| Jul 20, 2026 | John Oyler | Sale (10b5-1) | -1,512 | 477K |
| Jul 20, 2026 | John Oyler | Sale (10b5-1) | -523 | 165K |
| Jul 20, 2026 | John Oyler | Sale (10b5-1) | -280 | 89K |
| Jul 17, 2026 | John Oyler | Sale (10b5-1) | -1,440 | 439K |
| Jul 17, 2026 | John Oyler | Sale (10b5-1) | -597 | 183K |
| Jul 17, 2026 | John Oyler | Sale (10b5-1) | -680 | 210K |
| Jul 17, 2026 | John Oyler | Sale (10b5-1) | -4,833 | 1.5M |
| Jul 17, 2026 | John Oyler | Sale (10b5-1) | -5,543 | 1.7M |
| Jul 17, 2026 | John Oyler | Sale (10b5-1) | -35,829 | 11.2M |
| Jul 17, 2026 | John Oyler | Sale (10b5-1) | -14,915 | 4.7M |
| Jul 17, 2026 | John Oyler | Sale (10b5-1) | -740 | 233K |
| Jul 17, 2026 | John Oyler | Sale (10b5-1) | -51 | 16K |
| Jul 16, 2026 | John Oyler | Sale (10b5-1) | -233 | 73K |
| Jul 16, 2026 | John Oyler | Sale (10b5-1) | -4,881 | 1.5M |
| Jul 16, 2026 | John Oyler | Sale (10b5-1) | -9,516 | 3.0M |
| Jul 16, 2026 | John Oyler | Sale (10b5-1) | -19,752 | 6.2M |
| Jul 16, 2026 | John Oyler | Sale (10b5-1) | -32,224 | 10.2M |
| Jul 16, 2026 | John Oyler | Sale (10b5-1) | -42,798 | 13.6M |
| Jul 16, 2026 | John Oyler | Sale (10b5-1) | -6,402 | 2.0M |
| Jul 16, 2026 | John Oyler | Sale (10b5-1) | -15,097 | 4.8M |
| Jul 16, 2026 | John Oyler | Sale (10b5-1) | -20,505 | 6.6M |
| Jul 16, 2026 | John Oyler | Sale (10b5-1) | -13,109 | 4.2M |
| Jul 16, 2026 | John Oyler | Sale (10b5-1) | -1,560 | 503K |
| Jul 16, 2026 | John Oyler | Sale (10b5-1) | -520 | 168K |
| Jul 15, 2026 | John Oyler | Sale (10b5-1) | -6,067 | 1.9M |
| Jul 15, 2026 | John Oyler | Sale (10b5-1) | -41,336 | 12.9M |
| Jul 15, 2026 | John Oyler | Sale (10b5-1) | -12,857 | 4.0M |
| Jul 15, 2026 | John Oyler | Sale (10b5-1) | -48,657 | 15.2M |
| Jul 15, 2026 | John Oyler | Sale (10b5-1) | -7,640 | 2.4M |
| Jul 14, 2026 | John Oyler | Sale (10b5-1) | -4,139 | 1.3M |
| Jul 14, 2026 | John Oyler | Sale (10b5-1) | -8,122 | 2.5M |
| Jul 14, 2026 | John Oyler | Sale (10b5-1) | -39,090 | 11.9M |
| Jul 14, 2026 | John Oyler | Sale (10b5-1) | -45,895 | 14.1M |
| Jul 14, 2026 | John Oyler | Sale (10b5-1) | -40,781 | 12.5M |
| Jul 14, 2026 | John Oyler | Sale (10b5-1) | -7,834 | 2.4M |
| Jul 13, 2026 | John Oyler | Sale (10b5-1) | -798 | 241K |
| Jul 13, 2026 | John Oyler | Sale (10b5-1) | -4,584 | 1.4M |
| Jul 13, 2026 | John Oyler | Sale (10b5-1) | -26,294 | 8.0M |
| Jul 13, 2026 | John Oyler | Sale (10b5-1) | -8,438 | 2.6M |
| Jul 13, 2026 | John Oyler | Sale (10b5-1) | -846 | 259K |
| Jul 13, 2026 | John Oyler | Sale (10b5-1) | -7,240 | 2.2M |
| Jul 13, 2026 | John Oyler | Sale (10b5-1) | -320 | 98K |
| Jul 10, 2026 | John Oyler | Sale (10b5-1) | -1,493 | 442K |
| Jul 10, 2026 | John Oyler | Sale (10b5-1) | -1,314 | 391K |
| Jul 10, 2026 | John Oyler | Sale (10b5-1) | -3,074 | 917K |
| Jul 10, 2026 | John Oyler | Sale (10b5-1) | -5,143 | 1.5M |
| Jul 10, 2026 | John Oyler | Sale (10b5-1) | -370 | 111K |
| Jul 10, 2026 | John Oyler | Sale (10b5-1) | -150 | 45K |
| Jul 10, 2026 | John Oyler | Sale (10b5-1) | -136 | 41K |
| Jul 10, 2026 | John Oyler | Sale (10b5-1) | -18 | 5K |
| Jul 8, 2026 | Chan Henry Lee | Sale (10b5-1) | -664 | 201K |
| Jun 23, 2026 | John Oyler | Sale | -1,800 | 492K |
| Jun 23, 2026 | John Oyler | Sale | -1,290 | 354K |
| Jun 23, 2026 | John Oyler | Sale | -320 | 88K |
| Jun 23, 2026 | Xiaobin Wu | Sale | -1,292 | 357K |
| Jun 23, 2026 | Lai Wang | Sale | -1,068 | 296K |
| Jun 16, 2026 | John Oyler | Sale | -1,650 | 437K |
| Jun 16, 2026 | John Oyler | Sale | -1,710 | 455K |
| Jun 16, 2026 | John Oyler | Sale | -333 | 89K |
| Jun 16, 2026 | Xiaobin Wu | Sale | -1,357 | 362K |
| Jun 16, 2026 | Lai Wang | Sale | -1,169 | 310K |
| Jun 16, 2026 | Chan Henry Lee | Sale | -590 | 157K |
| Jun 11, 2026 | John Oyler | Sale | -741 | 190K |
| Jun 11, 2026 | John Oyler | Sale | -859 | 221K |
| Jun 11, 2026 | John Oyler | Sale | -200 | 52K |
| Jun 11, 2026 | John Oyler | Sale | -149 | 39K |
| Jun 11, 2026 | Titus B. Ball | Sale | -49 | 13K |
| Jun 11, 2026 | Titus B. Ball | Sale | -120 | 31K |
| Jun 11, 2026 | Xiaobin Wu | Sale | -626 | 164K |
| Jun 11, 2026 | Lai Wang | Sale | -756 | 197K |
| Jun 11, 2026 | Chan Henry Lee | Sale | -428 | 110K |
| Jun 11, 2026 | Aaron Rosenberg | Sale | -631 | 163K |
| Jun 8, 2026 | John Oyler | Sale | -3,820 | 1.0M |
| Jun 8, 2026 | John Oyler | Sale | -1,120 | 304K |
| Jun 8, 2026 | Titus B. Ball | Sale | -100 | 27K |
| Jun 8, 2026 | Titus B. Ball | Sale | -36 | 10K |
| Jun 8, 2026 | Xiaobin Wu | Sale | -1,444 | 389K |
| Jun 8, 2026 | Xiaobin Wu | Sale | -40 | 11K |
| Jun 8, 2026 | Lai Wang | Sale | -1,327 | 357K |
| Jun 8, 2026 | Lai Wang | Sale | -40 | 11K |
| Jun 8, 2026 | Chan Henry Lee | Sale | -711 | 192K |
| Jun 8, 2026 | Chan Henry Lee | Sale | -160 | 43K |
| Jun 1, 2026 | Qingqing Yi | Sale | -235 | 66K |
| May 22, 2026 | Baker Bros. Advisors LP / 667, L.P. / Baker Bros. Advisors (GP) LLC / Baker Brothers Life Sciences LP / Felix Baker / Julian Baker (indirect) | Sale | -2,743 | 65K |
| May 22, 2026 | Baker Bros. Advisors LP / 667, L.P. / Baker Bros. Advisors (GP) LLC / Baker Brothers Life Sciences LP / Felix Baker / Julian Baker (indirect) | Sale | -2,743 | 65K |
| May 22, 2026 | Baker Bros. Advisors LP / 667, L.P. / Baker Bros. Advisors (GP) LLC / Baker Brothers Life Sciences LP / Felix Baker / Julian Baker (indirect) | Sale | -2,756 | 66K |
| May 22, 2026 | Baker Bros. Advisors LP / 667, L.P. / Baker Bros. Advisors (GP) LLC / Baker Brothers Life Sciences LP / Felix Baker / Julian Baker (indirect) | Sale | -2,756 | 66K |
| May 22, 2026 | Corazon (Corsee) D. Sanders | Sale | -212 | 66K |
| May 22, 2026 | Alessandro Riva | Sale | -212 | 66K |
| May 22, 2026 | Margaret Dugan | Sale | -212 | 66K |
Show the other 155 trades
Sources
Form 4s from SEC's filing index. An insider files one within two business days of a trade.
Also
Insider selling plans: the 10b5-1 plans and Form 144 notices behind planned sales.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/ONC/export.csv") into a cell.